CAPTRUST Financial Advisors
ACET icon

CAPTRUST Financial Advisors’s Adicet Bio ACET Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5
Closed -$1K – 2076
2022
Q2 		$1K Buy
5
+1
+25% +$220 ﹤0.01% 4612
2022
Q1 		$1K Hold
4
– – ﹤0.01% 4641
2021
Q4 		$1K Buy
+4
New +$687 ﹤0.01% 4524

Other funds holding ACET

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CAPTRUST Financial Advisors's ACET Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Adicet Bio (ACET) in Q3 2022, closing a stake of 5 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in ACET in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 102 funds tracked by Wall St. Rank hold ACET as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Adicet Bio position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 5 Adicet Bio shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Adicet Bio in Q4 2021 and held it in 3 quarters.
  • CAPTRUST Financial Advisors's Adicet Bio position peaked at $1K in Q2 2022.
  • 102 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.